The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Effects of Testosterone Treatment in Older Men
Open accessAbstract
BACKGROUND: Serum testosterone concentrations decrease as men age, but benefits of raising testosterone levels in older men have not been established. METHODS: We assigned 790 men 65 years of age or older with a serum testosterone concentration of less than 275 ng per deciliter and symptoms suggesting hypoandrogenism to receive either testosterone gel or placebo gel for 1 year. Each man participated in one or more of three trials--the Sexual Function Trial, the Physical Function Trial, and the Vitality Trial. The primary outcome of each of the individual trials was also evaluated in all participants. RESULTS: Testosterone treatment increased serum testosterone levels to the mid-normal range for men 19 to 40 years of age. The increase in testosterone levels was associated with significantly increased sexual activity, as assessed by the Psychosexual Daily Questionnaire (P<0.001), as well as significantly increased sexual desire and erectile function. The percentage of men who had an increase of at least 50 m in the 6-minute walking distance did not differ significantly between the two study groups in the Physical Function Trial but did differ significantly when men in all three trials were included (20.5% of men who received testosterone vs. 12.6% of men who received placebo, P=0.003). Testosterone had no significant benefit with respect to vitality, as assessed by the Functional Assessment of Chronic Illness Therapy-Fatigue scale, but men who received testosterone reported slightly better mood and lower severity of depressive symptoms than those who received placebo. The rates of adverse events were similar in the two groups. CONCLUSIONS: In symptomatic men 65 years of age or older, raising testosterone concentrations for 1 year from moderately low to the mid-normal range for men 19 to 40 years of age had a moderate benefit with respect to sexual function and some benefit with respect to mood and depressive symptoms but no benefit with respect to vitality or walking distance. The number of participants was too few to draw conclusions about the risks of testosterone treatment. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00799617.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“there is accumulating evidence against a link between testosterone therapy and prostate cancer development.”
From Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018) · cites this paper as [24]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the ‘Testosterone Trials’, treatment with testosterone improved participants’ results in the 6 min walk test compared with placebo (20.5% versus 12.6%; P = 0.003)53.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Randomized controlled trials have shown that there is not a significant increase in the rate of a prostate cancer diagnosis in older, testosterone deficient men who were treated with testosterone compared to placebo.”
From Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In trials, patients with low testosterone have demonstrated statistically significant improvements in erectile function, 24 sex drive, 24 anemia, 25 bone mineral density, 26 lean body mass, 27 and depressive symptoms. 24”
From Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018) · cites this paper as [24]
In the citing paper
“Testosterone supplementation is also shown to benefit other aspects of health, including sexual function, physical function, vitality, quality of life and improved mood [109, 111].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [111]
In the citing paper
“Of note, potential improvements in muscle (and lean) mass may not directly result in improved muscle function214,215.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [214]
In the citing paper
“In the large T Trials, sexual function improved modestly with testosterone treatment,”
From Hypogonadism and male obesity: Focus on unresolved questions (2018) · cites this paper as [37]
In the citing paper
“suggesting that even older men with a relatively high comorbid burden (37% had diabetes and 15% a previous myocardial infarction) can respond to testosterone.37”
From Hypogonadism and male obesity: Focus on unresolved questions (2018) · cites this paper as [37]
In the citing paper
“In the Testosterone Trials of stringently selected symptomatic men with a baseline testosterone averaging < 9.5 nmol/L (275 ng/dL) for no apparent reason other than age, testosterone treatment had a modest benefit in sexual function, and some benefit with respect to mood and depressive symptoms (15).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“In an intensive lifestyle randomized controlled trial (RCT) of relatively healthy obese middle-aged men, 15% weight loss increased the mean International Index of Erectile Function (IIEF) score by 3.10, which is clinically meaningful (23) and similar to the increase of 2.64 reported in the Testosterone Trials, although those men were older (15).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“Although head-to-head studies are lacking, the efficacy reported for PDE5 inhibitors is greater than that reported for lifestyle intervention and testosterone treatment (15, 25).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“In RCTs of middle-aged and older men, where contraindications have been rigorously excluded and treatment was carefully monitored, short-term testosterone treatment has been associated with a low risk of adverse events (15).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“Although the trial was too small to reliably assess testosterone treatment-associated risks (15)”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“it does provide some assurance about the potential relative short-term safety of testosterone treatment in men without the previously mentioned contraindications.”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“These guideline recommendations are consistent with the exclusion criteria specified in the Testosterone Trials (15).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
In the citing paper
“In the 12-month Testosterone Trials, the rates of adverse events were similar in the testosterone- and placebo-treated men.”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Development and validation of brief measures of positive and negative affect: The PANAS scales.
Watson, D., Clark, L. A., & Tellegen, A. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.6.1063 · Cited by 32,433
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling
Terza, J. V., Basu, A., & Rathouz, P. J. (2008) · Journal of Health Economics · doi:10.1016/j.jhealeco.2007.09.009 · Cited by 1,728
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Self-citationThe International Index of Erectile Function (IIEF): a state-of-the-science review
Rosen, R., Cappelleri, J. C., & Gendrano, N. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900857 · Cited by 1,050
Self-citationRedelmeier, D. A., Bayoumi, A. M., Goldstein, R. S., & Guyatt, G. H. (1997) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.155.4.9105067 · Cited by 1,029
Flagged first, then by citations
2 of the 40 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Ware J, Kosinski M. SF-36 Physical and Mental Health Summary Scales: a manual for users of Version 1, Second Edition. Lincoln, RI: Quality Metric, 2005.
Cited by
Sorted by citations
Items 201–300 of 891
Pathways for salvage and protection of the heart under stress: novel routes for cardiac rejuvenation
Cannata, A. N., Camparini, L., Sinagra, G., Giacca, M., & Loffredo, F. S. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw106 · Cited by 34
Irwig, M. S., Fleseriu, M., Jonklaas, J., Tritos, N. A., Yuen, K. C. J., Correa, R. R., Elhomsy, G. C., Garla, V. V., Jasim, S., Soe, K. K., et al. (2020) · Endocrine Practice · doi:10.4158/ps-2019-0540 · Cited by 35
Gagliano‐Jucá, T., Travison, T. G., Nguyen, P. L., Kantoff, P. W., Taplin, M., Kibel, A. S., Manley, R., Hally, K., Bearup, R., Beleva, Y. M., et al. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2017.09.017 · Cited by 34
Self-citationLiu, C., Ma, J., Zhang, J., Zhao, H., Zhu, Y., Qi, J., Liu, L., Zhu, L., Jiang, Y., Tang, G., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00505 · Cited by 34
BMI1 Drives Steroidogenesis Through Epigenetically Repressing the p38 MAPK Pathway
Yu, J. J., Wu, Y., Li, H., Zhou, H., Shen, C., Gao, T., Lin, M., Dai, X., Ou, J., Liu, M., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.665089 · Cited by 34
Stephens‐Shields, A. J., Snyder, P. J., Ellenberg, S. S., Taylor, L., & Bhasin, S. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac028 · Cited by 35
Self-citationSexual Function and Testosterone Level in Men With Conservatively Treated Chronic Kidney Disease
Fugl-Meyer, K. S., Nilsson, M. I., Hylander, B., & Lehtihet, M. (2017) · American Journal of Men s Health · doi:10.1177/1557988317703207 · Cited by 35
Pfaff, D. W., & Baum, M. J. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.10.018 · Cited by 31
Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study
Gittelman, M., Jaffe, J. S., & Kaminetsky, J. C. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.08.013 · Cited by 32
Critical Illness and the Frailty Syndrome: Mechanisms and Potential Therapeutic Targets
Paul, J. A., Whittington, R. A., & Baldwin, M. R. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004792 · Cited by 37
Myokine, a key cytokine for physical exercise to alleviate sarcopenic obesity
Zhang, L., Lv, J., Wang, C., Ren, Y., & Ming, Y. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07821-3 · Cited by 33
Self-citationNowakowska, M. K., Ortega, R. M., Wehner, M. R., & Nead, K. T. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2023.0998 · Cited by 33
Effects of sex hormone-binding globulin (SHBG) on androgen bioactivity in vitro
Laurent, M. R., Helsen, C., Antonio, L., Schollaert, D., Joniau, S., Vos, M. J., Decallonne, B., Hammond, G. L., Vanderschueren, D., & Claessens, F. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.041 · Cited by 31
Gender Differences in Response to COVID-19 Infection and Vaccination
Zaher, K. A., Basingab, F. S., Alrahimi, J., Basahel, K., & Aldahlawi, A. (2023) · Biomedicines · doi:10.3390/biomedicines11061677 · Cited by 43
Walther, A., Rice, T., Kufert, Y., & Ehlert, U. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00206 · Cited by 34
Sesti, F. F., Pofi, R., Minnetti, M., Tenuta, M., Gianfrilli, D., & Isidori, A. M. (2020) · Andrology · doi:10.1111/andr.12876 · Cited by 31
Hackett, G. I., Cole, N., Mulay, A., Strange, R. C., & Ramachandran, S. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.180052m · Cited by 31
Association of Vaginal Estradiol Tablet With Serum Estrogen Levels in Women Who Are Postmenopausal
Mitchell, C. M., Larson, J. C., Crandall, C. J., Bhasin, S., LaCroix, A. Z., Ensrud, K. E., Guthrie, K. A., & Reed, S. D. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.41743 · Cited by 30
Self-citationErectile dysfunction in renal failure and transplant patients
Fiuk, J., & Tadros, N. N. (2019) · Translational Andrology and Urology · doi:10.21037/tau.2018.09.04 · Cited by 30
Mechanisms of honey on testosterone levels
Banihani, S. A. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02029 · Cited by 30
The Metabolic Syndrome in Central Hypogonadotrophic Hypogonadism
Dwyer, A. A., & Quinton, R. (2018) · Frontiers of hormone research · doi:10.1159/000485998 · Cited by 31
EMAS position statement: Testosterone replacement therapy in older men
Kanakis, G., Pofi, R., Goulis, D. G., Isidori, A. M., Armeni, E., Erel, C. T., Fistonić, I., Hillard, T., Hirschberg, A. L., Męczekalski, B., et al. (2023) · Maturitas · doi:10.1016/j.maturitas.2023.107854 · Cited by 35
The endocrinology of sarcopenia and frailty
Kamwa, V., Welch, C., & Hassan-Smith, Z. K. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03198-3 · Cited by 30
Fanni, E., Castellini, G., Corona, G., Boddi, V., Ricca, V., Rastrelli, G., Fisher, A. D., Cipriani, S., & Maggi, M. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.07.002 · Cited by 29
New Horizons in Klinefelter Syndrome: Current Evidence, Gaps, and Research Priorities
Lucas-Herald, A. K., Aksglæde, L., Caspersen, I. D., Ahmed, S. F., Carlomagno, F., & Isidori, A. M. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf005 · Cited by 28
Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
Traish, A. M. (2016) · Korean journal of urology · doi:10.4111/icu.2016.57.6.384 · Cited by 28
Testosterone Treatment of Depressive Disorders in Men
Bhasin, S., & Seidman, S. N. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.2661 · Cited by 28
Self-citationJasuja, G. K., Ameli, O., Reisman, J. I., Rose, A. J., Miller, D. R., Berlowitz, D. R., & Bhasin, S. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17141 · Cited by 28
Self-citationCunningham, G. R., Ellenberg, S. S., Bhasin, S., Matsumoto, A. M., Parsons, J. K., Preston, P. E., Cauley, J. A., Gill, T. M., Swerdloff, R. S., Wang, C., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00806 · Cited by 28
Self-citationWalsh, J., Marshall, H. C., Smith, I. L., Greenfield, D., Swain, J., Best, E. L., Ashton, J., Brown, J. M., Huddart, R. A., Coleman, R. E., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002960 · Cited by 29
Androgen regulation of behavioral stress responses and the hypothalamic-pituitary-adrenal axis
Zuloaga, D. G., Lafrican, J. J., & Zuloaga, K. L. (2024) · Hormones and Behavior · doi:10.1016/j.yhbeh.2024.105528 · Cited by 30
Kıvrak, M., Avcı, U., Uzun, H., & Ardıç, C. (2024) · Diagnostics · doi:10.3390/diagnostics14232634 · Cited by 27
Thirumalai, A., Cooper, L. A., Rubinow, K. B., Amory, J. K., Lin, D. W., Wright, J. L., Marck, B. T., Matsumoto, A. M., & Page, S. T. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1483 · Cited by 27
Self-citationMyopenia and precision (P4) medicine
Morley, J. E., & Anker, S. D. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12231 · Cited by 26
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model
Sarchielli, E., Comeglio, P., Filippi, S., Cellai, I., Guarnieri, G., Guasti, D., Rapizzi, E., Rastrelli, G., Bani, D., Vannelli, G. B., et al. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0532 · Cited by 27
Role of testosterone in cognition and mobility of aging men
Kaufman, J., & Lapauw, B. (2020) · Andrology · doi:10.1111/andr.12872 · Cited by 29
Testosterone replacement in aging men: an evidence-based patient-centric perspective
Bhasin, S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146607 · Cited by 27
Self-citationA Selective Androgen Receptor Modulator (OPK-88004) in Prostate Cancer Survivors: A Randomized Trial
Pencina, K. M., Burnett, A. L. “., Storer, T. W., Guo, W., Li, Z., Kibel, A. S., Huang, G. T.-W., Blouin, M., Berry, D. L., Basaria, S. S., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab361 · Cited by 28
Self-citationPalliative Care of Cancer in the Older Patient
Balducci, L., & Dolan, D. E. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0557-2 · Cited by 28
Deer, R., Dickinson, J. M., Baillargeon, J., Fisher, S. R., Raji, M. A., & Volpi, E. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz084 · Cited by 27
An Ensemble Perspective of Aging-Related Hypoandrogenemia in Men
Liu, P. Y., Takahashi, P. Y., & Veldhuis, J. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-53298-1_16 · Cited by 27
Emerging medication for the treatment of male hypogonadism
Aydoğdu, A., & Swerdloff, R. S. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1226799 · Cited by 25
Self-citationXia, K., Chen, H., Wang, J., Feng, X. G., Gao, Y., Wang, Y., Deng, R., Wu, C., Luo, P., Zhang, M., et al. (2020) · Theranostics · doi:10.7150/thno.46854 · Cited by 26
Self-citationInvernizzi, M., Alessandro de, S. I. R. E., & Fusco, N. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.02.003 · Cited by 27
Okpechi, S. C., Fong, J. T., Gill, S. S., Harman, J. C., Nguyen, T. H., Chukwurah, Q., Onor, I. O., & Alahari, S. K. (2021) · Aging and Disease · doi:10.14336/ad.2020.1211 · Cited by 26
Pastuszak, A. W., Gittelman, M., Tursi, J. P., Jaffe, J. S., Schofield, D., & Miner, M. M. (2021) · Andrology · doi:10.1111/andr.13108 · Cited by 28
Testosterone Replacement Therapy: The Emperor's New Clothes
Sansone, A., Sansone, M., Lenzi, A., & Romanelli, F. (2016) · Rejuvenation Research · doi:10.1089/rej.2016.1818 · Cited by 26
As we grow old: nutritional considerations for older patients on dialysis.
Johansson, L., Fouque, D., Bellizzi, V., Chauveau, P., Kolko, A., Molina, P., Sezer, S., ter Wee, P., Teta, D., & Carrero, J. (2016) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfw201 · Cited by 31
Smith, J. B., Rosen, J. H., & Colbert, A. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.08.007 · Cited by 26
Testosterone treatment in older men
(2016) · New England Journal of Medicine · doi:10.1056/nejmc1603665 · Cited by 25
Self-citationAllosterically Coupled Multisite Binding of Testosterone to Human Serum Albumin
Jayaraj, A., Schwanz, H. A., Spencer, D. J., Bhasin, S., Hamilton, J. A., Jayaram, B., Goldman, A. L., Krishna, M., Krishnan, M., Shah, A., et al. (2021) · Endocrinology · doi:10.1210/endocr/bqaa199 · Cited by 28
Self-citationSAÚDE PÚBLICA: EPIDEMIOLOGIA, CLÍNICA E ESTRATÉGIAS DE TRATAMENTO
Oliveira, C. P. D. C., da Silva, A. A., Filho, P. S. D. P. S., & Mota, L. P. (2023) · Paulo Sérgio da Paz Silva Filho eBooks · doi:10.56161/sci.ed.20230128 · Cited by 24
Testosterone Treatment in Middle-Aged and Older Men with Hypogonadism
Bhasin, S., & Snyder, P. J. (2025) · New England Journal of Medicine · doi:10.1056/nejmra2404637 · Cited by 27
Self-citationSalem, J., Bretagne, M., Lebrun‐Vignes, B., Waintraub, X., Gandjbakhch, E., Hidden‐Lucet, F., Gougis, P., Bachelot, A., & Funck‐Brentano, C. (2019) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2019.06.008 · Cited by 26
Male sexual dysfunction in obesity: The role of sex hormones and small fibre neuropathy
Ho, J. H., Adam, S., Azmi, S., Ferdousi, M., Liu, Y., Kalteniece, A., Dhage, S. S., Keevil, B. G., Syed, A. A., Ammori, B. J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221992 · Cited by 27
Livingston, M. A., Downie, P., Hackett, G. I., Marrington, R., Heald, A. H., & Ramachandran, S. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13607 · Cited by 25
Late-onset hypogonadism: Clinical evidence, biological aspects and evolutionary considerations
Jaschke, N., Wang, A., Hofbauer, L. C., Rauner, M., & Rachner, T. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101301 · Cited by 30
Jasuja, R., Pencina, K. M., Spencer, D. J., Peng, L., Privat, F., Dhillo, W. S., Jayasena, C. N., Hayes, F. J., Yeap, B. B., Matsumoto, A. M., et al. (2022) · Andrology · doi:10.1111/andr.13310 · Cited by 25
Self-citationGrossmann, M., Jayasena, C. N., & Anawalt, B. D. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad180 · Cited by 25
Effects of Testosterone on Erythropoiesis in a Female Mouse Model of Anemia of Inflammation
Guo, W., Schmidt, P. J., Fleming, M. D., & Bhasin, S. (2016) · Endocrinology · doi:10.1210/en.2016-1150 · Cited by 25
Self-citationZitzmann, M., Rohayem, J., Raidt, J., Kliesch, S., Kumar, N., Sitruk-Ware, R. L., & Nieschlag, E. (2017) · Andrology · doi:10.1111/andr.12328 · Cited by 25
Walther, A., Lacker, T. J., & Ehlert, U. (2017) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2017.11.021 · Cited by 27
Corona, G., Rastrelli, G., Sparano, C., Carinci, V., Casella, G., Vignozzi, L., Sforza, A., & Maggi, M. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2337741 · Cited by 26
Approach to the Patient: Low Testosterone Concentrations in Men With Obesity
Muir, C. A., Wittert, G., & Handelsman, D. J. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf137 · Cited by 26
Liang, Z., & Zhang, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1733798 · Cited by 32
Impact of recent FDA ruling on testosterone replacement therapy (TRT)
Metzger, S., & Burnett, A. L. “. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.09.08 · Cited by 24
Takayama, K. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0328 · Cited by 24
Haring, R., Ghannad, M., Bertizzolo, L., & Page, M. J. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.02.004 · Cited by 25
Lapauw, B., & Kaufman, J. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0394 · Cited by 24
Cannarella, R., Gusmano, C., Leanza, C., Garofalo, V., Crafa, A., Barbagallo, F., Condorelli, R. A., Vignera, S. L., & Calogero, A. E. (2023) · Asian Journal of Andrology · doi:10.4103/aja202352 · Cited by 27
GREEN, D. J., Chasland, L. C., Yeap, B. B., & Naylor, L. H. (2024) · Sports Medicine - Open · doi:10.1186/s40798-024-00703-x · Cited by 28
Testosterone and depressive symptoms among men in the Diabetes Prevention Program
Kim, C., Barrett-Connor, E. L., Aroda, V. R., Mather, K. J., Christophi, C. A., Horton, E. S., Pi-Sunyer, X., Bray, G. A., Labrie, F., & Golden, S. H. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.06.009 · Cited by 24
Self-citationHackett, G. I., Cole, N., Saghir, A., Jones, P. W., Strange, R. C., & Ramachandran, S. (2017) · Andrology · doi:10.1111/andr.12399 · Cited by 24
Traish, A. M. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00174.2016 · Cited by 23
A new 2% testosterone gel formulation: a comparison with currently available topical preparations
Arver, S., Stief, C. G., de la Rosette, J. J. M. C. H., Jones, T. H., Neijber, A., & Carrara, D. (2018) · Andrology · doi:10.1111/andr.12487 · Cited by 23
Miner, M. M., Morgentaler, A., Khera, M., & Traish, A. M. (2018) · Clinical Endocrinology · doi:10.1111/cen.13589 · Cited by 23
Finkelstein, J. S., Lee, H., Burnett‐Bowie, S. M., Darakananda, K., Gentile, E. C., Goldstein, D. W., Prizand, S. H., Krivicich, L. M., Taylor, A. P., Wulczyn, K. E., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa318 · Cited by 23
Jones, T. H., Dobs, A. S., Randeva, H. S., Moore, W., & Parkin, J. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad099 · Cited by 27
Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Rescue Testicular Aging
Luo, P., Chen, X., Gao, F., Xiang, A. P., Deng, C., Xia, K., & Gao, Y. (2024) · Biomedicines · doi:10.3390/biomedicines12010098 · Cited by 24
Mechanisms of Testosterone's Anabolic Effects on Muscle and Function: Controversies and New Insights
Bhasin, S., Wang, C., Chandra, M. R. G., Gagliano‐Jucá, T., & Jasuja, R. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf041 · Cited by 27
Self-citationErectile function after kidney transplantation: a meta-analysis
Kang, J., Tian, J. H., Lü, Y., Song, Y., & Liu, X. (2020) · Translational Andrology and Urology · doi:10.21037/tau-20-604 · Cited by 22
Contraception across transgender
Mancini, I., Alvisi, S., Gava, G., Seracchioli, R., & Meriggiola, M. C. (2021) · International Journal of Impotence Research · doi:10.1038/s41443-021-00412-z · Cited by 22
Grober, E. D., Krakowsky, Y., Khera, M., Holmes, D. T., Jc, L., Grantmyre, J. E., Patel, P., Bebb, R. A., Fitzpatrick, R., Campbell, J. D., et al. (2021) · Canadian Urological Association Journal · doi:10.5489/cuaj.7252 · Cited by 26
Alwhaibi, A. M., Alsanea, S., Almadi, B., Alsabhan, J. F., & Alosaimi, F. D. (2022) · The Aging Male · doi:10.1080/13685538.2022.2053954 · Cited by 22
Midttun, M., Overgaard, K., Zerahn, B., Pedersen, M., Rashid, A., Østergren, P. B., Paulin, T. K., Pødenphanth, T. W., Karlsson, L. K., Rosendahl, E., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13498 · Cited by 22
Rais, M., Wilson, R. M., Urbanski, H. F., & Messaoudi, I. (2017) · GeroScience · doi:10.1007/s11357-017-9979-5 · Cited by 22
Testosterone replacement therapy and the risk of stroke in men: A systematic review
Loo, S. Y., Chen, B. Y., Yu, O. H. Y., Azoulay, L., & Renoux, C. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.08.013 · Cited by 22
Testosterone, frailty and physical function in older men
Hsu, B., Cumming, R. G., & Handelsman, D. J. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1475227 · Cited by 22
Brito, M. M., Angrimani, D. D. S. R., Rui, B. R., Kawai, G. K. V., Losano, J. D. D. A., & Vannucchi, C. I. (2018) · The Aging Male · doi:10.1080/13685538.2018.1487931 · Cited by 22
New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
Karakas, S. E., & Surampudi, P. N. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.06.001 · Cited by 23
Glutamate in Male and Female Sexual Behavior: Receptors, Transporters, and Steroid Independence
Chiang, V. S., & Park, J. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.589882 · Cited by 21
Testosterone Replacement Therapy: A Narrative Review with a Focus on New Oral Formulations
Bhat, S. Z., & Dobs, A. S. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.2.133 · Cited by 23
Testosterone therapy in the new era of Food and Drug Administration oversight
Desroches, B. R., Kohn, T. P., Welliver, C., & Pastuszak, A. W. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.03.13 · Cited by 21
Testosterone Replacement Therapy and Components of the Metabolic Syndrome
Anaissie, J. E., Roberts, N. H., Wang, P., & Yafi, F. A. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.01.003 · Cited by 21
The emergence of sarcopenia as an important entity in older people
Offord, N., & Witham, M. D. (2017) · Clinical Medicine · doi:10.7861/clinmedicine.17-4-363 · Cited by 21
Testosterone replacement in men with sexual dysfunction
Lee, H., Hwang, E. C., Oh, C. K., Lee, S., Yu, H. S., Lim, J. S., Kim, H. W., Walsh, T. J., Kim, M. H., Jung, J. H., et al. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013071.pub2 · Cited by 20
Head and Neck Cancer and Sarcopenia: An Integrative Clinical and Functional Review
Endo, K., Ichinose, M., Kobayashi, E., Ueno, T., Hirai, N., Nakanishi, Y., Kondo, S., & Yoshizaki, T. (2024) · Cancers · doi:10.3390/cancers16203460 · Cited by 21
Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer
Bell, M. A., Campbell, J. D., Joice, G. A., Sopko, N. A., & Burnett, A. L. “. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.170007 · Cited by 20
Tran, C., Yeap, B. B., Ball, J., Clayton‐Chubb, D., Hussain, S. M., Brodtmann, A. G., Tonkin, A. M., Neumann, F., Schneider, H. G., Fitzgerald, S. M., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102611 · Cited by 22
Lundy, S. D., Parekh, N. V., & Shoskes, D. A. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.03.006 · Cited by 21
Metadata
- Authors
- Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., Ensrud, K. E., Lewis, C. E., Farrar, J. T., Cella, D., Rosen, R. C., Pahor, M., Crandall, J. P., Molitch, M. E., Cifelli, D., Dougar, D., Fluharty, L., Resnick, S. M., Storer, T. W., Anton, S., Basaria, S., Diem, S. J., Hou, X., Mohler, E. R., Parsons, J. K., Wenger, N. K., Zeldow, B., Landis, J. R., & Ellenberg, S. S.
- Affiliations
- University of Pennsylvania (US)
- Brigham and Women's Hospital (US)
- Baylor College of Medicine (US)
- University of Washington (US)
- From the Division of Endocrinology, Diabetes, and Metabolism (P.J.S.), the Department of Biostatistics and Epidemiology (A.J.S.-S., J.T.F., X.H., B.Z., J.R.L., S.S.E.), the Center for Clinical Epidemiology and Biostatistics (D. Cifelli, D.D., L.F.), and the Division of Cardiovascular Disease, Section of Vascular Medicine, Department of Medicine (E.R.M.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Research Program in Men’s Health: Aging and Metabolism, Brigham and Women’s...
- University of Pittsburgh (US)
- Yale University (US)
- University of California San Diego (US)
- The Lundquist Institute (US)
- University of Minnesota (US)
- Northwestern University (US)
- New England Research Institutes (US)
- University of Florida (US)
- Albert Einstein College of Medicine (US)
- National Institutes of Health (US)
- Emory University (US)
- ORCID
- Snyder, Peter J.
- Bhasin, Shalender
- Cunningham, Glenn R.
- Matsumoto, Alvin M.
- Cauley, Jane A.
- Gill, Thomas M.
- Barrett-Connor, Elizabeth
- Swerdloff, Ronald S.
- Wang, Christina
- Ensrud, Kristine E.
- Lewis, Cora E.
- Farrar, John T.
- Cella, David
- Crandall, Jill P.
- Molitch, Mark E.
- Resnick, Susan M.
- Storer, Thomas W.
- Anton, Stephen
- Basaria, Shehzad
- Diem, Susan J.
- Hou, Xiaoling
- Parsons, J. Kellogg
- Wenger, Nanette K.
- Zeldow, Bret
- Landis, J. Richard
- Ellenberg, Susan S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-02-18
- Volume
- 374
- Issue
- 7
- Pages
- 611-624
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC5209754
- OpenAlex
- W2324158400
- Cited by
- 890
- References
- 40
- Citations by year
- 2026: 49 · 2025: 73 · 2024: 73 · 2023: 97 · 2022: 79 · 2021: 65 · 2020: 81 · 2019: 76 · 2018: 103 · 2017: 106 · 2016: 86
- FWCI
- 124.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p60dk079626-05, UL1TR000142)
- National Institute on Aging (U01AG030644, P30-AG013679, R01AG037679, K24AG021507, K07AG043587, R01 AG37679, P30AG024827, P30AG028740, P30AG021342)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK079626, P60-DK-079626, P30DK079626)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Keywords
- testosterone replacement therapy, older men, hypogonadism, testosterone gel, sexual function, erectile function, sexual desire, physical function, walking distance, vitality, depressive symptoms, mood, adverse events
- MeSH terms
- Aged, Depression, Double-Blind Method, Fatigue, Humans, Libido, Male, Reference Values, Sexual Behavior, Testosterone, Walking, Prostate-Specific Antigen, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
